Down-regulation of Active ACK1 is Mediated by Association with the E3 Ubiquitin Ligase Nedd4-2

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Jan 16

PMID 19144635

Citations 42

Authors

Wing Chan

Rui Tian

Yeow-Fong Lee

Soon Tuck Sit

Louis Lim

Ed Manser

Affiliations

Soon will be listed here.

Abstract

ACK1 (activated Cdc42-associated kinase 1) is a cytoplasmic tyrosine kinase implicated in trafficking through binding to epidermal growth factor (EGF) receptor and clathrin. Here, we have identified a new ACK1-binding partner, the E3 ubiquitin ligase Nedd4-2, which binds ACK1 via a conserved PPXY-containing region. We show that this motif also binds Nedd4-related proteins and several other WW domain-containing proteins, including the tumor suppressor oxidoreductase Wwox. In HeLa cells ACK1 colocalizes with Nedd4-2 in clathrin-rich vesicles, requiring this PPXY motif. Nedd4-2 strongly down-regulates ACK1 levels when coexpressed, and this process can be blocked by proteasome inhibitor MG132. ACK1 degradation via Nedd4 requires their mutual interaction and a functional E3 ligase; it is also driven by ACK1 activity. ACK1 is polyubiquitinated in vivo, and dominant inhibitory Nedd4 blocks endogenous ACK1 turnover in response to acute EGF treatment. Because EGF stimulation activates ACK1 ( Galisteo, M., Y., Y., Urena, J., and Schlessinger, J. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 9796-9801 ), our result suggest that EGF receptor-mediated ACK1 activation allows Nedd4-2 to drive kinase degradation. Thus the interplay between Nedd4-2-related E3 ligases that regulate ACK1 levels and Cbl that modifies EGF receptor impinges on cell receptor dynamics. These processes are particularly pertinent given the report of genomic amplification of the ACK1 locus in metastatic tumors.

Citing Articles

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.

Eshaq A, Flanagan T, Hassan S, Al Asheikh S, Al-Amoudi W, Santourlidis S Cancers (Basel). 2024; 16(15).

PMID: 39123481 PMC: 11311543. DOI: 10.3390/cancers16152754.

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor.

Zhang M, Zhang Z, Tian X, Zhang E, Wang Y, Tang J Front Pharmacol. 2023; 14:1291773.

PMID: 38027016 PMC: 10666796. DOI: 10.3389/fphar.2023.1291773.

Investigation of Glycosylphosphatidylinositol (GPI)-Plasma Membrane Interaction in Live Cells and the Influence of GPI Glycan Structure on the Interaction.

Kundu S, Jaiswal M, Babu Mullapudi V, Guo J, Kamat M, Basso K Chemistry. 2023; 30(8):e202303047.

PMID: 37966101 PMC: 10922586. DOI: 10.1002/chem.202303047.

ACKnowledging the role of the Activated-Cdc42 associated kinase (ACK) in regulating protein stability in cancer.

Hodder S, Fox M, Binti Ahmad Mokhtar A, Mott H, Owen D Small GTPases. 2023; 14(1):14-25.

PMID: 37194323 PMC: 10193877. DOI: 10.1080/21541248.2023.2212573.

Host factor TNK2 is required for influenza virus infection.

Zhou A, Zhang W, Wang B Genes Genomics. 2023; 45(6):771-781.

PMID: 37133719 DOI: 10.1007/s13258-023-01384-8.

References

Mahajan N, Whang Y, Mohler J, Earp H . Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res. 2005; 65(22):10514-23. DOI: 10.1158/0008-5472.CAN-05-1127. View

van der Horst E, Degenhardt Y, Strelow A, Slavin A, Chinn L, Orf J . Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci U S A. 2005; 102(44):15901-6. PMC: 1276100. DOI: 10.1073/pnas.0508014102. View

Xu D, Makkinje A, Kyriakis J . Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J Biol Chem. 2004; 280(4):2924-33. DOI: 10.1074/jbc.M408907200. View

Galisteo M, Yang Y, Urena J, Schlessinger J . Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci U S A. 2006; 103(26):9796-801. PMC: 1502533. DOI: 10.1073/pnas.0603714103. View

Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S . WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem. 2003; 278(44):43169-77. DOI: 10.1074/jbc.M308009200. View

Katz M, Shtiegman K, Tal-Or P, Yakir L, Mosesson Y, Harari D . Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic. 2002; 3(10):740-51. DOI: 10.1034/j.1600-0854.2002.31006.x. View

Shen F, Lin Q, Gu Y, Childress C, Yang W . Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation. Mol Biol Cell. 2006; 18(3):732-42. PMC: 1805115. DOI: 10.1091/mbc.e06-02-0142. View

Reggiori F, Pelham H . Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J. 2001; 20(18):5176-86. PMC: 125630. DOI: 10.1093/emboj/20.18.5176. View

Marmor M, Yarden Y . Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene. 2004; 23(11):2057-70. DOI: 10.1038/sj.onc.1207390. View

10.

Yang W, Lin Q, Guan J, Cerione R . Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1. J Biol Chem. 1999; 274(13):8524-30. DOI: 10.1074/jbc.274.13.8524. View

11.

Ortolan T, Tongaonkar P, Lambertson D, Chen L, Schauber C, Madura K . The DNA repair protein rad23 is a negative regulator of multi-ubiquitin chain assembly. Nat Cell Biol. 2000; 2(9):601-8. DOI: 10.1038/35023547. View

12.

Omerovic J, Santangelo L, Puggioni E, Marrocco J, DallArmi C, Palumbo C . The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation. FASEB J. 2007; 21(11):2849-62. DOI: 10.1096/fj.06-7925com. View

13.

Hicke L . Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol. 2001; 2(3):195-201. DOI: 10.1038/35056583. View

14.

Yokoyama N, Miller W . Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck. J Biol Chem. 2003; 278(48):47713-23. DOI: 10.1074/jbc.M306716200. View

15.

Teo M, Tan L, Lim L, Manser E . The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J Biol Chem. 2001; 276(21):18392-8. DOI: 10.1074/jbc.M008795200. View

16.

Doong H, Rizzo K, Fang S, Kulpa V, Weissman A, Kohn E . CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem. 2003; 278(31):28490-500. DOI: 10.1074/jbc.M209682200. View

17.

Yeow-Fong L, Lim L, Manser E . SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1. FEBS Lett. 2005; 579(22):5040-8. DOI: 10.1016/j.febslet.2005.07.093. View

18.

Manser E, Leung T, Salihuddin H, Tan L, Lim L . A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature. 1993; 363(6427):364-7. DOI: 10.1038/363364a0. View

19.

Wilkinson C, Seeger M, Hartmann-Petersen R, Stone M, Wallace M, Semple C . Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol. 2001; 3(10):939-43. DOI: 10.1038/ncb1001-939. View

20.

Haglund K, Shimokawa N, Szymkiewicz I, Dikic I . Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc Natl Acad Sci U S A. 2002; 99(19):12191-6. PMC: 129420. DOI: 10.1073/pnas.192462299. View